annual D&A:
$2.29M+$558.00K(+32.22%)Summary
- As of today (September 17, 2025), EWTX annual depreciation & amortization is $2.29 million, with the most recent change of +$558.00 thousand (+32.22%) on December 31, 2024.
- During the last 3 years, EWTX annual D&A has risen by +$2.02 million (+741.91%).
- EWTX annual D&A is now at all-time high.
Performance
EWTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$567.00K+$13.00K(+2.35%)Summary
- As of today (September 17, 2025), EWTX quarterly depreciation & amortization is $567.00 thousand, with the most recent change of +$13.00 thousand (+2.35%) on June 30, 2025.
- Over the past year, EWTX quarterly D&A has increased by +$33.00 thousand (+6.18%).
- EWTX quarterly D&A is now -9.86% below its all-time high of $629.00 thousand, reached on December 31, 2024.
Performance
EWTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.35M+$33.00K(+1.42%)Summary
- As of today (September 17, 2025), EWTX TTM depreciation & amortization is $2.35 million, with the most recent change of +$33.00 thousand (+1.42%) on June 30, 2025.
- Over the past year, EWTX TTM D&A has increased by +$263.00 thousand (+12.59%).
- EWTX TTM D&A is now at all-time high.
Performance
EWTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EWTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.2% | +6.2% | +12.6% |
| 3 y3 years | +741.9% | +268.2% | +456.0% |
| 5 y5 years | +1761.8% | +1160.0% | +2667.1% |
EWTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +741.9% | -9.9% | +516.3% | at high | +456.0% |
| 5 y | 5-year | at high | +1761.8% | -9.9% | +1160.0% | at high | +2667.1% |
| alltime | all time | at high | +1761.8% | -9.9% | +1317.5% | at high | +5780.0% |
EWTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $567.00K(+2.3%) | $2.35M(+1.4%) |
| Mar 2025 | - | $554.00K(-11.9%) | $2.32M(+1.3%) |
| Dec 2024 | $2.29M(+32.2%) | $629.00K(+4.5%) | $2.29M(+4.4%) |
| Sep 2024 | - | $602.00K(+12.7%) | $2.19M(+5.0%) |
| Jun 2024 | - | $534.00K(+1.7%) | $2.09M(+3.6%) |
| Mar 2024 | - | $525.00K(-1.5%) | $2.02M(+16.4%) |
| Dec 2023 | $1.73M(+221.9%) | $533.00K(+7.2%) | $1.73M(+34.2%) |
| Sep 2023 | - | $497.00K(+7.8%) | $1.29M(+34.6%) |
| Jun 2023 | - | $461.00K(+91.3%) | $959.00K(+47.1%) |
| Mar 2023 | - | $241.00K(+162.0%) | $652.00K(+21.2%) |
| Dec 2022 | $538.00K | $92.00K(-44.2%) | $538.00K(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $165.00K(+7.1%) | $524.00K(+23.9%) |
| Jun 2022 | - | $154.00K(+21.3%) | $423.00K(+32.2%) |
| Mar 2022 | - | $127.00K(+62.8%) | $320.00K(+17.6%) |
| Dec 2021 | $272.00K(+47.0%) | $78.00K(+21.9%) | $272.00K(+11.5%) |
| Sep 2021 | - | $64.00K(+25.5%) | $244.00K(+35.6%) |
| Jun 2021 | - | $51.00K(-35.4%) | $180.00K(+3.4%) |
| Mar 2021 | - | $79.00K(+58.0%) | $174.00K(+28.9%) |
| Dec 2020 | $185.00K(+50.4%) | $50.00K(+11.1%) | $135.00K(+58.8%) |
| Jun 2020 | - | $45.00K(+12.5%) | $85.00K(+112.5%) |
| Mar 2020 | - | $40.00K | $40.00K |
| Dec 2019 | $123.00K | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual D&A year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM D&A year-on-year change?
What is Edgewise Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of EWTX is $2.29M
What is the all time high annual D&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual depreciation & amortization is $2.29M
What is Edgewise Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, EWTX annual depreciation & amortization has changed by +$558.00K (+32.22%)
What is Edgewise Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of EWTX is $567.00K
What is the all time high quarterly D&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly depreciation & amortization is $629.00K
What is Edgewise Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, EWTX quarterly depreciation & amortization has changed by +$33.00K (+6.18%)
What is Edgewise Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of EWTX is $2.35M
What is the all time high TTM D&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM depreciation & amortization is $2.35M
What is Edgewise Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, EWTX TTM depreciation & amortization has changed by +$263.00K (+12.59%)